Eribulin Mesylate 43598-0125
Product NDC
43598-0125- Manufacturer
- Dr. Reddys Laboratories Inc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 22, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA217473
Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eribulin Mesylate | .5 mg/mL |
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (43598-125-11) / 2 mL in 1 VIAL, SINGLE-DOSE